Scientists from Doheny Eye Institute to Present Latest Vision Research at ARVO 2025

More than 25 researchers to share findings at global ophthalmology conference as institute's leader concludes term as ARVO president
Published on Apr 28, 2025

Pasadena-based Doheny Eye Institute announced Wednesday that over 25 of its scientists and clinician-scientists will present research at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting on May 4-8 in Salt Lake City.

The institute, recognized as one of the nation’s leading vision research organizations, will have strong representation at the premier global eye research conference. Doheny’s presence is further highlighted as Dr. SriniVas R. Sadda concludes his term as ARVO president at the meeting’s end.

Dr. Sadda serves as Director of Artificial Intelligence & Imaging Research at Doheny and holds the A. Ray Irvine, Jr., MD, Endowed Chair.

“The impressive number of Doheny scientists and clinician-scientists selected to present at this year’s ARVO Annual Meeting highlights the innovation and importance of Doheny’s research contributions to ophthalmology,” said Dr. Deborah A. Ferrington, Chief Scientific Officer at Doheny Eye Institute. “This also presents a great opportunity for our scientists and clinician-scientists to collaborate with other leaders in vision research, identifying new approaches, and share knowledge to help us accelerate efforts toward our shared goal of eliminating preventable blindness.”

Two Doheny researchers were selected for the conference’s prestigious Mini symposia sessions. Dr. Kaustabh Ghosh, Principal Investigator at Doheny and Associate Professor of Ophthalmology at UCLA, will present on “Mechanobiology: A Fresh Perspective on Diabetic Retinopathy” on May 5. Yuhua Zhang, PhD, Principal Investigator and Professor of Ophthalmology at UCLA, will discuss “Adaptive Optics Imaging of Age-Related Macular Degeneration” on May 6.

Doheny scientists will also present papers and posters on topics ranging from age-related macular degeneration to healthcare access and glaucoma prevalence.

The institute will co-host two events with UCLA Stein Eye Institute: the annual Doheny-UCLA Breakfast Forum on May 4, focusing on “Oculomics: Accelerating Discovery of Systemic Disease Mechanism,” and the Annual ARVO Alumni Reception on May 5.

Doheny Eye Institute has been at the forefront of vision science for over 75 years. Since 2013, its affiliation with UCLA Stein Eye Institute has strengthened their combined position in vision research, education and patient care. U.S. News & World Report ranks them as among the top five vision centers in the U.S.

For more information, visit www.doheny.org.

Make a Comment

  • (not be published)